*Human Pai 1 Recombinant Latent N Terminal MutationIHUPAI1RLNT500UG
Select this product for Molecular Innovations name, N-Terminal Cys mutant (latent wild type) and product number, NTCYSPAI-L.
Human PAI-1 Recombinant Latent N Terminal Mutation from Innovative Research has been recombinantly produced in E. coli and purified by affinity chromatography. This is a Frozen liquid buffered in 0.1M HEPES; 0.1M NaCl; 1mM DTT; pH 7.4 with a concentration of 2.5 mg/ml and a purity of >95% as determined by SDS-PAGE.
- Species: Human
- Target: PAI-1
- Purification Method: Affinity purified
- Purity: >95% as determined by SDS-PAGE Analysis
- Source: E. coli
- Storage Conditions: -70 C
Wild type PAI-1, cloned, with a cysteine residue at the N-terminus. The latent fraction is less than than 0.4% active. The protein is supplied in buffer with 1 mM DTT to prevent dimerization.
This product can be used as a control in applications like ELISA and Western Blot. It can be used in a wide range of in vitro applications, including blocking/inhibition, fibrinolysis, plasminogen activation, receptor binding, in hypertension studies, for protein-protein interactions, and more. At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
These products are supplied for manufacturing, research and laboratory use only. Researchers and laboratory personnel intending to use any of these products for medical investigation on humans are solely responsible for such use and for compliance with the pertinent regulations of the United States Food and Drug Administration (US-FDA) and other regulations. We do not assume liability for damages resulting from the handling, use and/or disposal of these products, from their use in violation of patent or other rights or reliance upon this information.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Get in touch with our team! Please include any relevant information (product name, etc)